Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases
The ratio of angiopoietins ANG‐1 and ANG‐2 regulates vessel quiescence and neoangiogenesis as well as barrier function. It also acts as a switch from health to neovascular eye diseases.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
14 October 2016
|
| In: |
EMBO molecular medicine
Year: 2016, Volume: 8, Issue: 11, Pages: 1265-1288 |
| ISSN: | 1757-4684 |
| DOI: | 10.15252/emmm.201505889 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.15252/emmm.201505889 Verlag, lizenzpflichtig, Volltext: https://www.embopress.org/doi/abs/10.15252/emmm.201505889 
|
| Author Notes: | Jörg T. Regula, Peter Lundh von Leithner, Richard Foxton, Veluchamy A. Barathi, Chui Ming Gemmy Cheung, Sai Bo Bo Tun, Yeo Sia Wey, Daiju Iwata, Miroslav Dostalek, Jörg Moelleken, Kay G. Stubenrauch, Everson Nogoceke, Gabriella Widmer, Pamela Strassburger, Michael J. Koss, Christian Klein, David T. Shima & Guido Hartmann |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1745538887 | ||
| 003 | DE-627 | ||
| 005 | 20230426074302.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210125s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.15252/emmm.201505889 |2 doi | |
| 035 | |a (DE-627)1745538887 | ||
| 035 | |a (DE-599)KXP1745538887 | ||
| 035 | |a (OCoLC)1341389092 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Regula, Jörg Thomas |e VerfasserIn |0 (DE-588)1111527156 |0 (DE-627)865599505 |0 (DE-576)47614261X |4 aut | |
| 245 | 1 | 0 | |a Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases |c Jörg T. Regula, Peter Lundh von Leithner, Richard Foxton, Veluchamy A. Barathi, Chui Ming Gemmy Cheung, Sai Bo Bo Tun, Yeo Sia Wey, Daiju Iwata, Miroslav Dostalek, Jörg Moelleken, Kay G. Stubenrauch, Everson Nogoceke, Gabriella Widmer, Pamela Strassburger, Michael J. Koss, Christian Klein, David T. Shima & Guido Hartmann |
| 264 | 1 | |c 14 October 2016 | |
| 300 | |a 24 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 19.02.2021 | ||
| 520 | |a The ratio of angiopoietins ANG‐1 and ANG‐2 regulates vessel quiescence and neoangiogenesis as well as barrier function. It also acts as a switch from health to neovascular eye diseases. | ||
| 700 | 1 | |a Koss, Michael Janusz |d 1979- |e VerfasserIn |0 (DE-588)131446819 |0 (DE-627)509448690 |0 (DE-576)298483521 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a European Molecular Biology Organization |t EMBO molecular medicine |d [London] : Nature Publishing Group UK, 2009 |g 8(2016), 11, Seite 1265-1288 |h Online-Ressource |w (DE-627)594772761 |w (DE-600)2485479-7 |w (DE-576)305355961 |x 1757-4684 |7 nnas |
| 773 | 1 | 8 | |g volume:8 |g year:2016 |g number:11 |g pages:1265-1288 |g extent:24 |a Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases |
| 856 | 4 | 0 | |u https://doi.org/10.15252/emmm.201505889 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.embopress.org/doi/abs/10.15252/emmm.201505889 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210125 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 131446819 |a Koss, Michael Janusz |m 131446819:Koss, Michael Janusz |d 50000 |e 50000PK131446819 |k 0/50000/ |p 15 | ||
| 999 | |a KXP-PPN1745538887 |e 3841793851 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["European Molecular Biology Organization (EMBO)"]},"id":{"issn":["1757-4684"],"zdb":["2485479-7"],"eki":["594772761"],"doi":["10.1002/(ISSN)1757-4684"]},"origin":[{"publisherPlace":"[London] ; Heidelberg ; Weinheim","dateIssuedDisp":"[2009]-","publisher":"Nature Publishing Group UK ; EMBO Press ; Wiley-VCH"}],"corporate":[{"roleDisplay":"VerfasserIn","display":"European Molecular Biology Organization","role":"aut"}],"language":["eng"],"recId":"594772761","disp":"European Molecular Biology OrganizationEMBO molecular medicine","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 5. November 2022","Fortsetzung der Druck-Ausgabe"],"part":{"year":"2016","issue":"11","pages":"1265-1288","volume":"8","text":"8(2016), 11, Seite 1265-1288","extent":"24"},"pubHistory":["Vol. 1, No. 1 (Apr 1, 2009)-"],"title":[{"title":"EMBO molecular medicine","title_sort":"EMBO molecular medicine"}]}],"physDesc":[{"extent":"24 S."}],"id":{"doi":["10.15252/emmm.201505889"],"eki":["1745538887"]},"origin":[{"dateIssuedDisp":"14 October 2016","dateIssuedKey":"2016"}],"name":{"displayForm":["Jörg T. Regula, Peter Lundh von Leithner, Richard Foxton, Veluchamy A. Barathi, Chui Ming Gemmy Cheung, Sai Bo Bo Tun, Yeo Sia Wey, Daiju Iwata, Miroslav Dostalek, Jörg Moelleken, Kay G. Stubenrauch, Everson Nogoceke, Gabriella Widmer, Pamela Strassburger, Michael J. Koss, Christian Klein, David T. Shima & Guido Hartmann"]},"language":["eng"],"recId":"1745538887","note":["Gesehen am 19.02.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases","title_sort":"Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases"}],"person":[{"role":"aut","display":"Regula, Jörg Thomas","roleDisplay":"VerfasserIn","given":"Jörg Thomas","family":"Regula"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Koss, Michael Janusz","given":"Michael Janusz","family":"Koss"}]} | ||
| SRT | |a REGULAJOERTARGETINGK1420 | ||